|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.4000 - 2.5300|
|52 Week Range||1.6070 - 7.8940|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Green Organic Dutchman's Valleyfield Facility Receives Organic Certification from Internationally Recognized Pro-Cert
L'installation de Valleyfield de TGOD reçoit la certification biologique de Pro-Cert, une agence de certification reconnue internationalement
TORONTO, June 20, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce its expansion into the global organic hemp CBD market with the launch of its Global Strategic Hemp Division. This new division will leverage TGOD's solid expertise in the European hemp CBD market to fuel growth and accelerate the development and commercialization of new products across its network of international partners.
Shares of Neptune Wellness Solutions Inc. rallied Wednesday, after the Canada-based company announced a second 3-year extraction agreement with a cannabis company in a week.
Shares of Neptune Wellness Solutions Inc. shot up 11% toward a record high in premarket trade Wednesday, after the Canada-based extraction and purification company announced a 3-year agreement with cannabis company Green Organic Dutchman Holdings Ltd. . Under terms of the agreement, Green Organic will supply more than 230,000 kilograms of cannabis and hemp biomass to Neptune, which will extract and purify cannabinoids and terpenes, to be transformed into organic finished products. The first shipment of biomass is expected to be received in September 2019. The deal comes less than a week after Neptune announced a 3-year extraction and purification agreement with cannabis company Tilray Inc. , that sent Neptune's stock to a record close on Friday. Neptune's stock has rallied 39.3% over the past three months while Green Organic shares have shed 20.5%, the ETFMG Alternative Harvest ETF has lost 11.0% and the S&P 500 has gained 3.4%.
TORONTO, June 12, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that it has entered into a multi-year agreement with Neptune Wellness Solutions Inc. ("Neptune") (NEPT) (NEPT.TO) for extraction, formulation and packaging services. As part of the agreement, TGOD will have exclusivity on extraction, formulation and packaging of certified organic products within and for the Canadian market.
LAVAL, QC , June 12, 2019 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NEPT) (NEPT), has entered into a definitive long-term agreement to provide extraction, formulation and packaging services to The Green Organic Dutchman Holdings Ltd. ("TGOD") (TGOD.TO) (TGODF). Neptune will extract and purify cannabinoids and terpenes from cannabis and hemp biomass received from TGOD.
TORONTO, June 11, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (US:TGODF) is pleased to announce the voting results from its annual general meeting of shareholders of the Company ("Shareholders"), held in Mississauga, Ontario on June 11, 2019 (the "Meeting"). All of the matters put forward before Shareholders for consideration and approval as set out in the Company's management information circular dated May 9, 2019 (the "Circular") were approved by the requisite majority of votes cast at the Meeting.
Green Organic Dutchman (TGODF) is one of those cannabis stocks that it seems either investors love or hate. Even those who give some props to the company, it is usually presented in a way that the negative catalysts outweigh the positive catalysts.Most of that comes from the lack of revenue as a result of the company building out facilities that, for the most part, have yet to become operational.That is rapidly changing. The company estimates it should produce about 65,000 kilograms of cannabis a year by the end of 2019, and by the latter part of 2021, it guides for production capacity to soar to 219,000 kilograms a year. That would place it in the top 5 of Canadian producers as they stand today.Of that total, about 20 percent will be used in edibles and infused beverages.Negative catalystsThere are several key negative catalyst that have been expressed toward Green Organic, including lagging its competitors in implementing its strategy, uncertainty in regard to whether or not the beverages and edibles market will be as robust as expected, and the suggestion its plans may be too ambitious.As far as falling behind the general market, I'm not as concerned here as I would be with most other cannabis producers. The major reason for that is it's competing in the specialized premium organic pot market. That market is in earlier stages than the general recreational and medical cannabis markets, so it isn't as important to garner share as quickly as companies that compete in multiple segments of the cannabis market. Demand from organic cannabis users will seek out quantity and quality, and Green Organic Dutchman, once it starts delivering product at significant levels, should be very attractive to that market.Concerning beverages and edibles, that is a legitimate concern. That said, the Canadian market is different than the American market, which has struggled because of mixed signals from authorities concerning infused drinks and edibles. Canada is probably going to be a lot clearer in those areas because of being more accepting of cannabis in general.As for its plans being too ambitious, I don't see that as an issue. Those that end up being market leaders on the production side of the business are going to have to produce a lot of cannabis to enjoy the flexibility it offers them. I don't see how, over time, the smaller producers are going to be able to survive once recreational cannabis demand approaches a ceiling.Overall, the major problem I see for Green Organic is it simply has to show the market what it can do. That means it'll take patience to see how the company is able to perform once it starts generating revenue.Positive catalystsProbably the most important positive catalyst for Green Organic is its business model itself. The decision to compete primarily in the premium organic segment at a high production level does set it apart from most of its competition.Once it ramps up production, and assuming it can sell at wide margins and generate positive earnings and cash flow, it will be rewarded by investors. It doesn't even have to do that immediately; it only has to show it's clearly heading in that direction.Another huge positive catalyst for Green Organic is its expanding international presence, which is seems many financial pundit, writers and commentators aren't aware of or are discounting at this point.Counting joint ventures and partnerships, it will compete in markets like Germany, United Kingdom, Italy, France, Spain, Denmark, Poland, Portugal, Switzerland, Portugal, Mexico, Ireland, and a number of smaller markets. It will primarily target the medical segment of those countries.The good news to me is it's putting these things into place before it seriously ramps up its production. This should allow it to get everything in order so it can launch a relatively smooth entry into the domestic and foreign markets.Again, under most circumstances falling behind its peers as it is perceived, would be a big negative for the company, but in the segment it competes in, it shouldn't limit its future growth potential.Green Organic will focus on supplying the Canadian market first, but it will roll out its international strategy as supply becomes available.Revenue, spending and its balance sheetIn this particular stage of its development, I'm really not interested in the revenue or losses reported in its earnings report, as they're not indicative of the performance of the company over the next year or two.In the last quarter it generated C$2.4 million, with a net loss of C$14.1 million. During the quarter it spent C$46.9 million, with most of that coming from its construction of facilities.That could be a concern in relationship to its burn rate, but when considering it has a hefty C$224.4 million in cash and restricted cash on its balance sheet, and revenue expected to start to climb in the latter part of 2019, this shouldn't be a serious issue with the company.It should also have plenty left to spend on its international growth and expansion.ConclusionI don't think it's going to be too long before investors start to see the potential in the Green Organic Dutchman. In my view, it's more the uncertainty surrounding the inability to analyze the company yet because it hasn't entered into its growth stage, which is rapidly approaching.Once that kicks into gear, the market will get a better feel for its performance. It'll also get more clarity with margins and earnings once it starts to generate revenue. After all, if there is little revenue, it's impossible to measure profitability and how long it'll take to achieve it. In my view, this is probably the biggest reason the market has held back in viewing the stock more favorably.At this time the organic pot market is under served, and if Green Organic Dutchman can rapidly fill in the demand, it could enter into a prolonged growth phase which would reward shareholders nicely.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on TGODF: * Seaport Releases Updated Estimates for The Green Organic Dutchman * The Green Organic Dutchman Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast * The Green Organic Dutchman Is a Better Value Stock More recent articles from Smarter Analyst: * Last Minute Thought: Buy or Sell Netflix (NFLX) Stock Before Q2’19 Earnings? * Is It Finally Time to Go Long NIO Stock? This Analyst Remains Sidelined * Rosenblatt: Buy AMD Stock Ahead of Q2 Earnings and Toss Aside Intel (INTC) * Stifel's Top Analyst Bullish on Netflix (NFLX) Stock Ahead of 2Q:19 Earnings
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
TORONTO , May 30, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce, further to its news release of February 6, 2019 , that it will effect on June 3, 2019 (the "Distribution Date") the distribution of unit purchase warrants ("SpinCo Unit Warrants") of TGOD Acquisition Corp. ("SpinCo") to all registered TGOD shareholders of record as of January 31, 2019 (the "Distribution Record Date") who elected to receive the SpinCo Unit Warrants (the "Distribution") under its previously announced plan of arrangement with SpinCo (the "Arrangement").
Despite the very strong gains in cannabis stocks, there were also several sharp sell-offs lately that caught investors off guard. Much of that weakness is the result of recent earnings results. Although major players such as Aurora Cannabis (ACB) have seen their revenue grow in the wake of the legalization of Canadian recreational cannabis, it's unclear when these companies will become sustainably profitable.Meanwhile, widely followed cannabis analyst Brett Hundley did a deep dive on Aurora Cannabis, Tilray (TLRY) and The Green Organic Dutchman (TGODF) in a note on Monday.Hundley updated his Aurora model, following the company's fiscal Q3 earnings report earlier this month:> We now expect positive EBITDA of $3MM in Q4 compared to previous IFRS-based expectations of a loss of $21.9MM. As we adjust forward EBITDA expectations for FY20 and FY21, our estimates drop across the board, due mainly to lower revenue expectations as we alter views around production, sale and pricing. For FY21, we now anticipate EBITDA of $246.2MM, a meaningful decline from our previous forecast of $340.9MM. If we look at our FY21 EBITDA estimate in terms of margin, we now anticipate a 24.2% return on sales vs.a previous margin view of 27.2%.The analyst reiterates a Neutral rating on ACB stock without providing a price target.Most of the Street is more confident than Hundley's sidelined stance, with TipRanks analytics showcasing ACB as a Strong Buy. Based on 7 analysts polled by in the last 3 months, 6 rate a Buy on Aurora Cannabis stock while only Hundley maintains a Hold. The 12-month average price target stands at $9.21, marking a nearly 10% upside from where the stock is currently trading. (Read more on ACB)Next up is Tilray. The Canadian marijuana producer released its quarterly report on May 14, beating estimates for first-quarter revenue, while meeting Wall Street's expectations for losses. Revenue increased 195% to $23 million and the company lost an adjusted $0.27 per share.Hundley has a few updates for Tilray as well:> Our EBITDA estimates for FY19 and FY20 are relatively unchanged; we now anticipate FY19 EBITDA of ($34.4MM) and FY20 EBITDA of $20.3MM, mostly in-line with previous expectations. For FY21, we are dropping revenue expectations to $670.1MM from a previous view of $751MM, based on updated views around production, sale and pricing. Our new model does include new production and processing capacity as part of the company's recently disclosed capital investment plan. Despite a drop in revenue expectations for the year, we now forecast FY21 EBITDA of $140.6MM relative to our previous view of $134.2MM. We now expect better performance on the gross margin line, somewhat offset by the anticipation of a more robust SG&A profile.The analyst reiterates a Neutral rating on TLRY, without suggesting a price target.Ultimately, the word on the Street points to a sidelined majority on TLRY stock. In the last three months, the pot stock has landed 3 ‘buy’ ratings vs. 5 ‘hold’ and 3 'sell' ratings. It’s clear that Wall Street is largely divided between the bulls and the bears when it comes to Tilray's market opportunity. That said, the consensus average price target points to $88.20, or over 100$ upside potential for the stock. This suggests that by consensus expectations, for now, the bulls win big time. (Read more on TLRY)Last, but not the least, is The Green Organic Dutchman. Hundley reiterates a Buy rating on TGODF stock, but lower his price target to $9.00 (from $10.00). Why? Let's take a look:> We bring down revenue expectations for FY19, FY20 and FY21, due to updated assumptions around production, sale and pricing. Our EBITDA forecasts across all three years come down as well, as a result. For FY21, we now expect EBITDA of $143.3MM relative to previous expectations of $159.5MM. Given our updated view of forward financials, our price target on the shares drops to $9 from $10. We maintain our Buy rating on the stock, based on an expectation that the company will be able to both scale production and sell organic product into the marketplace. We continue to be encouraged by added distribution agreements in recent weeks.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on the stocks mentioned: * Love or Hate Aurora Cannabis (ACB) Stock, That’s Where the Money Is * The Good and the Bad News for Aurora Cannabis (ACB) Stock * Tilray (TLRY) Is a Great Cannabis Company, But the Stock Is Overvalued * The Green Organic Dutchman Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast More recent articles from Smarter Analyst: * Top Analyst Dives in on Qualcomm (QCOM) Stock Amid Court Battle * This Analyst Continues to Hold a Bullish View on General Electric (GE) Stock * Why Cronos (CRON) Stock Still Has What It Takes * Despite Uncertainty, the Speculative Case for CannTrust (CTST) Stock Is Still Solid
The Green Organic Dutchman Holdings Ltd. (OTC: TGODF ) announced Friday that it secured a cannabis supply agreement with Alberta Gaming, Liquor & Cannabis, expanding its Western Canadian footprint. What ...
Canadian cannabis company The Green Organic Dutchman (TGODF) reported fiscal Q1 2019 earnings late Tuesday. It's Monday now and, if this is the first you've heard of the news -- don't be surprised. "TGOD" didn't exactly make a lot of headlines with its earnings news, and investors mostly slept through the report.TGOD stock was up a mere 1.4% on Wednesday after the report ... and flatlined on Thursday and Friday -- no change at all.Why so little fanfare? After all, didn't TGOD grow its sales 28% year over year in Q1?Well, yes, it did. However, even that strong growth rate still left TGOD selling little more than a corporate-scale dime bag of product for the quarter -- $2.4 million, to be precise. And TGOD didn't even make a profit on the transaction. To the contrary, TGOD reported a $14.1 million net loss in Q1, "as it continues its preparation for commercial production and entry into the recreational market later this year," said management.So how did Wall Street analysts react to the report? Well, let's see here. Seaport Global's Brett Hundley, which has taken a keen interest in Canadian pot stocks of late, opined that TDOG's miniscule sales were at least "in line with expectations for Q1," while the company's "EBITDA loss ... was slightly worse than anticipated.""No matter," though, said Hundley (his words, not ours). Because in the analyst's view, "reported results are largely immaterial and much of the forward focus for this company remains on the potential for forward commercialization and consumer adoption."Hundley, it seems, is viewing TGOD not so much as a business (which is, you know, supposed to make sales and earn profit) as his is seeing the company as a story stock -- which only really needs to tell a compelling tale to attract investor interest. And in this regard, the analyst sees TGOD as succeeding: * TGOD "remains on track for its build-out of facilities." (Translation: It hasn't built a lot of facilities yet). * And TGOD "intends to enter the Canadian adult-use market in ON and BC during Q4, before expanding nationally in 2020." (Translation: It hasn't yet managed to break into the Canadian adult-use market -- nationally or otherwise). * Perhaps most tellingly of all, Hundley notes that of the $2.4 million in sales TGOD did make during the quarter, these sales were "primarily derived from the company's HemPoland subsidiary, consistent with Q4."And if you recall, TGOD bought HemPoland last August, so most of the sales the company made... came from another company that it bought.If all of the above has you wondering what it is, exactly, that Hundley sees in TGOD that merits a "buy" rating (and the analyst does indeed recommend buying TGOD stock), well, you're not alone. A lot of investors yesterday and the day before seem to have wondered the same thing. That being said, there is one small factor to consider that may shed a ray of hope for TGOD bulls.To wit, TGOD operates in the high-margin "organic" segment of the marijuana market, and Hundley says it's been successful selling organic marijuana flower for as much as $12 a gram (and other pot companies have gotten even better prices). Considering that TGOD eventually hopes to produce organic marijuana for as little as $1 a gram, that seems to offer a lot of room for robust profit margins.Whether those margins will ever be robust enough to justify TGOD's current valuation of 247 times sales, of course, remains to be seen.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on TGOD: The Green Organic Dutchman Offers the Best Value for Investors More recent articles from Smarter Analyst: * Tesla (TSLA) Scrambles to Restore Faith; Wedbush Remains Cautions on the Stock * Micron (MU) Stock Has a New Bull * Has Roku Stock Price Hit Its Peak? * Will Qualcomm (QCOM) Stock Win Again? Canaccord Remains Bullish
Green Organic Dutchman's Losses Narrow as Revenue Rises in Q1TGOD Q1 earningsGreen Organic Dutchman Holdings (TGOD) (TGODF) reported its first-quarter earnings yesterday after the markets closed. It reported revenues of $2.4 million in the quarter,
TORONTO , May 14, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three months ended March 31, 2019 . Is on-track with construction at Hamilton and Valleyfield sites, with investment amounting to $46.9 million in the first quarter of 2019, an increase of $7.4 million compared to $39.5 million incurred in the fourth quarter 2018. Launched its Grower's Circle on March 25 th, 2019, commencing direct to patient medical sales in Canada with products from its existing Hamilton facility.